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Abstract
In Parkinson’s disease, motor fluctuations (worsening of tremor, bradykinesia, freezing of gait, postural instability) affect
up to 70% of patients within 9 years of l-dopa therapy. Nevertheless, the assessment of motor fluctuations is difficult in a
medical office, and is commonly based on poorly reliable self-reports. Hence, the use of wearable sensors is desirable. In this
preliminary trial, we have investigated bradykinesia and freezing of gait—FOG—symptoms by means of inertial measurement
units. To this purpose, we have employed a single smartphone on the patient’s waist for FOG experiment (38 patients), and
on patient thigh for LA (93 subjects). Given the sound performance achieved in this trial (AUC = 0.97 for FOG and AUC
= 0.92 for LA), motor fluctuations may be estimated in domestic environments. To this end, we plan to perform measures
and data processing on SensorTile, a tiny IoT module including several sensors, a microcontroller, a BlueTooth low-energy
interface and microSD card, implementing an electronic diary of motor fluctuations, posture and dyskinesia during activity
of daily living.
Keywords Parkinson’s disease · Wearable sensors · Personalized medicine · Tele-health
1 Introduction
The availability of low-cost, low-power, accessible Informa-
tion and Communication Technology (ICT) can be profitably
applied in the field of life sciences. Increasing evidence sup-
ports the effectiveness of tele-health systems from both the
social and the economic standpoint [1]. Remote monitoring
can provide a constant and objective, cost-effective follow-up
of patients, so addressing an important health demand.
Parkinson’s disease (PD) is the second most common
neuro degenerative disorder after Alzheimer’s disease [2].
Recent surveys estimate that 7–10 million people are affected
by PD worldwide, and the prevalence of the disease exceeds
1.9% over the age of 80 years. PD patients suffer from both
motor and non-motor symptoms, related to the degeneration
of dopamine neurons, especially in (but not limited to) the
B Gabriella Olmo
gabriella.olmo@polito.it
1 Department of Control and Computing Engineering,
Politecnico di Torino, Turin, Italy
2 Department of Neuroscience Rita Levi Montalcini, University
Hospital Città della Salute e della Scienza, Regional
Reference Center for Parkinson’s Disease and Movement
Disorders, Turin, Italy
substantia nigra region of the midbrain. The reason for this
cell death is not completely understood, but is related to the
piling up of degenerate proteins into the so-called Lewy bod-
ies in the neurons. The most common, idiopathic PD form
stems from a complex interplay between genetic predisposi-
tion and environmental factors, such as exposure to pesticides
and a history of head injuries.
The cardinal motor symptoms of PD define the so-called
parkinsonian syndrome, first described in 1817 by Dr. James
Parkinson as the paralysis agitans (shaking palsy). They
encompass rigidity, tremor at rest (i.e., disappearing during
voluntary movements), bradykinesia and postural instability
[2]. The onset of motor symptoms is typically asymmetric,
with an arm affected first. Then, signs and symptoms spread
to the other limb on the same side, and with the progres-
sion of the disease also affect the opposite side. On the other
hand, non-motor symptoms include olfactory impairment,
orthostatic hypotension, constipation, sleep disturbances and
speech impairment. Behavioral problems, depression and
anxiety frequently occur, and dementia is quite common in
the advanced stages of the disease [3].
l-Dopa has been the main PD treatment for over 40 years.
However, in advanced stages, patients may alternate periods
of good disease control (on state), with others of poor con-
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trol and significant PD symptoms (off state). Up to 50% of
patients can develop mild motor fluctuations within 2 years of
l-dopa therapy, and 70% after 9 years [4]. Another symptom
in later stages of the disease is freezing of gait (FOG), a form
of akinesia defined as a brief, episodic absence or marked
reduction of forward progression of the feet despite having
intention to walk [5,6]. It may be elicited by activities such
as initiation of gait, turning, passing though narrow spaces,
negotiating obstacles or performing dual tasks [7]. FOG is
strictly related to the risk of falls [8]; it limits the patient’s
autonomy and impairs his/her quality of life (QoL).
Even though the control of motor fluctuations is a key
clinical need for PD patients, such symptoms are diffi-
cult to appreciate in the outpatients department, and their
assessment is often based on poorly reliable self-reports and
questionnaires [9,10]. On the other hand, lightweight, wear-
able inertial sensors may enable an effective identification
and tracking of motor complications. The remote monitoring
of motor fluctuations in PD patients can allow the clinicians
to develop a thorough clinical picture of each patient, using
the large amount of data made available by modern sensors
and processing technologies. This can enable personalized
follow-up of each patient, proper and timely adjustment of
drug posology, and ultimately a cost reduction due to less
access to the emergency departments and hospitalizations.
This is inline with the modern paradigm of personalized
medicine.




Bradykinesia Bradykinesia is a pathologically slow move-
ment and an impaired ability to move following a command.
Besides unusually slow movements, other common aspects
of bradykinesia include shuffling and dragging one or both
feet when walking, reduced facial expressions, difficulties
in implementing repetitive tasks. The circadian evolution of
bradykinesia depends on the fluctuating response to drugs.
At present, bradykinesia, as well an many other aspects
of PD, is assessed by means of clinical scores such as
MDS-UPDRS (Unified Parkinson’s Disease Rating Scale),
promoted by the Movement Disorder Society (MDS) [11].
This rating scale encompasses six parts. Part I aims at
assessing mental state, behavior, mood, pain and autonomic
functions. Part II is a patient self-evaluation of several daily
activities. Part IV scores possible complications such as dysk-
inesia and fluctuations of several clinical conditions, and Part
V and VI take into account the severity of the disease (Hoehn
and Yahr scale) and the disability degree.
On the other hand, Part III is the clinical evaluation of
several motor skills, and takes into account speech impair-
ment, facial expressiveness, tremor, rigidity, hand sensitivity
and mobility, leg agility, dexterity in getting up from a chair,
posture and postural stability, gait characteristics, bradykine-
sia and hypo-akinesia. The clinician assigns a score between
0 and 4 according to the severity of the symptom at hand,
and following proper guidelines. This approach is not free
of criticism, as it may lack repeatability and is affected by
both intra- and inter-rater variability [12,13]. Furthermore,
the clinical evaluation, performed only within pre-scheduled
follow-up sessions, makes virtually impossible for the neu-
rologist to appreciate short-term variations of the patient’s
disability level and to plan proper therapy adjustments.
Leg agility (LA) is included in the MDS-UDPRS Part
III for motor evaluation of lower limbs. This test consists
of raising and stomping each foot on the ground at least
10 times, as high and as fast as possible, starting from a
sitting posture. According to the MDS guidelines, the task
scores should encompass the following parameters: speed of
execution, amplitude, slowing, hesitations and interruptions.
LA is strictly correlated to bradykinesia [14]. For this rea-
son, and due to its simplicity of execution and relatively easy
assessment, in this paper, we have selected LA as an indirect
measure of bradykinesia.
FOG A thorough knowledge of FOG frequency, duration
and response to drug therapy provides the neurologist with
valuable information on motor fluctuations and disease pro-
gression. Nevertheless, the clinical assessment of FOG is
very difficult. Its episodic nature makes it hard to appreci-
ate FOG events during pre-scheduled follow-up sessions in
the medical office. The probability of suffering a FOG event
increases with the time elapsed since the last l-dopa admin-
istration; moreover, it is dependent on the patient’s attention,
emotional state and on many other cognitive factors [15–17].
Inevitably, the FOG assessment is based on self-reports, lit-
tle correlated with the events appreciated in the outpatients
department [18,19]. From these considerations, it turns clear
that only long-term observation, possibly carried on during
activities of daily living (ADL), can provide a reliable assess-
ment of this phenomenon.
The motivation of this work lies in the need for quantita-
tive methods to assess the motor conditions of PD patients
in their ADL. Monitoring the daily fluctuations of the motor
symptoms can allow the clinicians to adapt the drug posol-
ogy to the specific response of the single patient. The use
of low-cost, low-power wearable sensors, as well as pow-
erful machine learning (ML)-based classification techniques
can provide effective and supportive treatment, accessible to
all patients also in a context of overall cost reduction. Our
objective is to implement a sort of electronic diary of the
patient during ADL, and to check the effectiveness of such
an electronic diary, in terms of reliability of measures during
non-supervised activities, overall user acceptance and cost.
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We use low-cost, easy-to-use instrumentation and keep the
patient’s acceptance and comfort as a key issue.
As a feasibility study, we have first investigated the use
of common smartphone sensors to collect accelerometer and
gyroscopic data, and have evaluated the performance of sev-
eral ML algorithms to assess PD bradykinesia and FOG. For
bradykinesia, we have carried out measures related to the LA
test. As for FOG detection, participants have performed a 6-
min walking test (6MWT) with frequent pauses and turning.
Moreover, to evolve towards ADL, providing information
about the number, duration and daily distribution of FOG
episodes, we have also monitored patients during the main
activities of their pre-scheduled follow-up visit, so that to
catch different activities.
The rest of this paper is organized as follows. In Sect. 2,
we discuss the state-of-the art in the field of PD symptom
monitoring with automated tools.
In Sect. 3, we describe the experimental setup and the
cohort of PD patients enrolled for the preliminary exper-
iments using smartphones for LA evaluation and FOG
detection, as well as the ML algorithms implemented, along
with the achieved results. In Sect. 4, we describe the Sensor-
Tile IoT module, along with the preliminary results achieved
with this platform for PD patients’ monitoring. Finally, in
Sect. 6, we discuss the evolutions of the present work towards
the creation of an effective electronic diary, and we draw the
conclusions.
2 Background
Many papers address the use of wearable devices in health-
care applications, to promote physical activity [20], evaluate
elderly people conditions [21], enable real-time inertial data
treatment [22]. Moreover, many recent papers have been
published related to remote monitoring, analysis and quan-
tification of PD motor symptoms using wearable inertial
measurement units (IMUs). The main differences concern
the number and localization of such sensors, the experimen-
tal setup and the achieved sensitivity and specificity of the
addressed algorithms. A thorough review of works in this
field can be found in [23]. Several papers make use of data-
mining techniques and ML systems to estimate the severity
of PD cardinal motor symptoms. In Ref. [24], ten clinically
diagnosed PD patients and ten control participants were pro-
vided with a low-cost Android OS smartphone, and were
asked to perform short exercises related to voice, posture,
gait, and finger tapping, four times a day. The method could
effectively discriminate PD patients from controls, and the
authors claim that it is useful for monitoring the disease pro-
gression, even though this task has not been demonstrated.
Many papers address upper limb bradykinesia by imple-
menting the finger-tapping task or digital spiral analysis
[25–28]. Lower limb bradykinesia is estimated in Refs. [29–
31], using several IMUs placed on different body segments,
and implementing motion analysis. In Refs. [32,33], an esti-
mation of some MDS-UPDRS Part III tasks, namely LA,
gait analysis and sit-to-stand, is performed using three IMUs
located on the patient’s chest and thighs. Several ML algo-
rithms are employed, to assess their capability of reproducing
the MDS-UPDRS evaluation yielded by expert neurologists;
the results have been validated using a state-of-the-art opto-
electronic system. These studies are comparable with ours in
terms of methodology (e.g., type of sensors employed and
position). Furthermore, the cardinality of the patients sets
for each UPDRS class are similar: in our study, we address
class 0: 21.8%, class 1: 45.6%, class 2: 21.8%, class 3: 8.1%
whereas in Refs. [32,33] the distribution is class 0: 19%, class
1: 46%, class 2: 30%, and class 3: 5%. Hence, in this paper
our results are compared with those in Refs. [32,33].
In Ref. [34], a single IMU, placed on the patient’s chest,
estimates the MDS-UPDRS sit-to-stand score in a controlled
environment. However, to the best of our knowledge, little
attention has been devoted to the assessment of lower limb
bradykinesia using a common smartphone and its sensors
as the measurement unit, to be used during ADL, hence in
non-supervised conditions.
A variety of wearable IMUs have been proposed for objec-
tive assessment of FOG. Yet, there is little agreement con-
cerning their number, location, experimental protocols and
data-processing algorithms. Dedicated tri-axial accelerom-
eters are commonly addressed, either alone [35–37], or
combined with gyroscopes [38,39] or magnetometers [40].
Both a single location and a combination of two or more
locations have been addressed. The shin [38,40] and waist
[35,41] are considered suitable as single locations. When
two or more sensor sets are employed, they are placed also
on feet [42], knee [43], thigh [44], chest [45] or wrist [46].
Smartphones are used as assistants in fitness applications
[47,48], heart rate monitoring [49], gait recognition [50],
and Human Activity Recognition (HAR) [51–53]. The use
of smartphones for detecting FOG episodes is proposed in
[39,41,54,55]. Experimental protocols encompass timed up-
and-go on a standardized 5-m course [41,42], walking tasks
and turns with or without FOG provocation [44,46,56] or dual
tasking (e.g., carrying a full glass of water while walking)
[36,39]. Some experimental protocols emulate unconstrained
ADL in laboratory [36,44] or at patient’s home [57,58]. All
protocols encompass video recordings during data acquisi-
tion, with videos labeled by clinicians offline.
The data-processing techniques are various. Threshold
algorithms are very simple and provide reasonable perfor-
mance [56], but require the optimal threshold to be tuned on
every single patient [42]. Naive Bayes (NB) [45], random
forest (RF) [57] and support vector machine (SVM) [36,58]
are commonly addressed ML algorithms. NB and RF are
123
Journal of Reliable Intelligent Environments
computationally less demanding than SVM, but this latter
exhibits higher accuracy and robustness [59]. In Ref. [41],
20 PD subjects wearing a waist-worn smartphone execute a
walking test, and accelerometer data are processed by means
of a threshold-based algorithm, achieving sensitivity, speci-
ficity, precision, and accuracy of 87.6%, 95.0%, 69.6% and
84.4%, respectively. In Ref. [58], SVM is employed, with
data measured on 21 PD patients equipped with a waist-worn
IMU; sensitivity and specificity turned out to be 74.7% and
79.0%. In Ref. [37], the Continuous Wavelet Transform is
used for FOG identification on 10 PD patients wearing three
accelerometers on shank, thigh and waist, achieving sensitiv-
ity and specificity of 83.0% and 67.0%, at the expenses of a
remarkable computational burden. In [60], a model based on
convolutional neural networks is applied on data from 21 PD
patients wearing an IMU on their waist, achieving sensitivity,
specificity, and accuracy of 92.6%, 88.0% and 87.0% respec-
tively. In [55], a smartphone is placed in the patient’s trouser
pocket, and data are represented as 2D images and transferred
to a remote server for processing. The methods achieves sen-
sitivity, specificity, accuracy of 93.8% 90.1% and 91.8%,
respectively, at the expenses of a quite high computational
complexity. In general, we believe that these results are very
encouraging, even though direct comparison is not straight-
forward, as the studies address different experimental setup
and rather small patient cohorts for algorithm validation.
3 PDmonitoring using smartphones
In this section, we describe the experimental setup and the
cohort of PD patients enrolled for the preliminary exper-
iments using smartphones for LA evaluation and FOG
detection. The ML algorithms implemented are described,
along with the achieved results.
3.1 Dataset
The study has been carried on at the Regional Reference
Center for Parkinson’s Disease and Movement Disorders,
University Hospital Città della Salute e della Scienza, Turin,
Italy, and at the Associazione Amici Parkinson Piemonte, a
private association of PD patients in Turin. The experiments
are in accordance with the Declaration of Helsinki. Partic-
ipants received detailed information on the study purposes
and execution, and written informed consent was obtained.
Demographic and clinical data were noted anonymously. The
study was approved by the local Ethics Committee.
A total number of 93 patients (mean age: 69, range: 43–87;
mean age at diagnosis: 60.1, range: 39–81; Hoehn and Yahr
score: 2.3, range: 1–4) were recruited for LA experiment.
Instead, FOG study involved 38 subjects (mean age: 70.7,
range: 44–84; mean age at diagnosis: 59.9, range: 36–77;
Table 1 Participants’ demographic and clinical characteristics
Number of participants Mean age
(years ± SD)
Years from diagnosis
93 (70% male) 69 ± 10 9.0 ± 6,5
38 (75% male) 70.7 ± 8.2 9 ± 4.8
1st row: PD LA experiment; 2nd row: PD FOG experiment
Table 2 Smartphone sensors technical characteristics
Sensor type Range Resolution fs
Accelerometer ± 2 g 40 mg 200 Hz
Gyroscope ± 34.9 rad/s 1.1 mrad/s 200 Hz
Hoehn and Yahr score: 2.5, range: 2–4). The inclusion crite-
ria for PD patients were a clinical diagnosis of PD with motor
symptoms [61], no major comorbidities, dementia or vision
impairments. During the test execution, most PD patients
were in different stages of their daily on state: they had taken
their usual drug dose, and they had not yet reached the time
of subsequent dose, even though different time intervals had
elapsed of each patient. Subjects needing gait assistance (e.g.,
walking stick, crutch) were included in both groups (patients:
21.1 %). The characteristics of the two populations are sum-
marized in Table 1. Please note that about 70% PD patients
are male in both studies; this is in line with the well-known
fact that the relative risk is 1.5 times greater in men than it is
in women [62].
In the first stage of this study, we employed a Samsung
S5 mini-smartphone. The technical characteristics of the
embedded inertial sensors are summarized in Table 2. Since
acceleration signals related to human activity lay in the 0–20
Hz band [63], with amplitudes ranging between ± 1 g dur-
ing walking [64] and ± 2 g during running [65], the sensors
included in the smartphone largely meet the requirements in
terms of sample frequency, resolution and dynamic range.
3.2 LA detection: experimental protocol
In the evaluation of the LA task, and following the MDS-
UPDRS guidelines, subjects were asked to sit in a straight-
backed chair and place the foot on the ground in a comfortable
position. Then, after being properly instructed by the expert
neurologists, the subjects performed the LA task from the
UPDRS Motor Section III with each leg separately. A Velcro
armband equipped with the Samsung S5 mini-smartphone
was fixed to the patient’s thigh, with the y-axis parallel to the
femur direction. Figure 1 shows the experimental setup. Data
were locally stored by means of SensorLog, a commercial
app for Android 6.0 [66]. Globally, we have measured 184
LA tests, as 2 patients were able to perform the test with a
single leg only.
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Fig. 1 Smartphone position adopted for the LA task
Fig. 2 Distribution of the UPDRS scores assigned to the LA tasks. 0:
normal (40 repetitions). 1: slight (84). 2: mild (40). 3: moderate (15).
4: severe (5) [11]
During the experiment, the LA task was scored by an
expert neurologist, and the obtained UPDRS Motor Sec-
tion III ratings have been employed as class labels for the
supervised classification algorithms. Figure 2 shows the dis-
tribution of the assigned scores. As in most similar measures,
the dataset encompasses few cases in classes UPDRS 3 and
4, as the clinical conditions of patients belonging to such
classes are severe, and may even prevent them from execut-
ing the task. Hence, the distribution of the UPDRS scores is
right-skewed.
Data from accelerometer, gyroscope and orientation sen-
sors have been collected, exported in CSV format and
processed offline using Matlab, version 2018a for Win-
dows 10. First, raw signals were recalibrated to compensate
for slight deviations from the ideal positioning (i.e., gravity
Table 3 List of features used for LA detection
Feature Description
n. 1 Number of movements
n. 2 Mean time interval between movements
n. 3 STD of the time intervals
n. 4 Thigh inclination trend
n. 5 Mean peak value
n. 6 Max peak value
n. 7 Max angular velocity value
n. 8 Max acceleration value
n. 9 RMS of angular velocity signal
n. 10 RMS of acceleration signal
n. 11 Range of acceleration signal
n. 12 Range of angular velocity signal
n. 13 Dominant frequency angular velocity
n. 14 Ratio of dominant frequency power to total
n. 15 Entropy of angular velocity signal
n. 16 Entropy of acceleration signal
Features related to orientation/angular velocity and acceleration refer
to x-axis and z-axis, respectively
acting only on the vertical component, perpendicular to the
smartphone screen. Then, after being preprocessed using a
Chebyshev type I low-pass filter with a cutoff frequency of
3.5 Hz and stopband attenuation equal to 20 dB at 4 Hz,
data have been processed to extract the relevant kinematic
features to feed the ML algorithms.
Features were selected to be representative of the major
traits that distinguish motion in PD patients and unaffected
controls, reflecting the same aspects that the clinician is called
to evaluate in the UPDRS scoring. Similar studies [29,30,32,
67,68] have also been taken into account. The 16 selected
features are listed in Table 3 and briefly described in the
following.
The number of leg movements is the number of peaks in
the pitch signal. Since the UPDRS rating requests at least
10 foot beats for the LA task, this feature can distinguish
between patients who can accomplish the task and those who
cannot. The i th time interval I (i) between consecutive thigh
movements is defined as I (i)  tP (i+1)−tP (i), where tP (i)
is the time associated with the peak of the (i)th repetition.
The feature used in this analysis is the mean interval over 10
repetitions of the foot stomping on the ground (or over the
number of actually executed foot movements, if the patient
is unable to perform 10 repetitions). The standard deviation
of the previously defined time intervals yields information
about the steadiness of movements, expected to be inferior
in PD patients with respect to controls. The thigh inclina-
tion trend, i.e., the trend of the thigh inclination from the
beginning to the end of the LA sessions, is represented by
the peak amplitudes evolution over time. We have considered
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Fig. 3 Time trajectories of x-axis angular velocity for LA UPDRS scores ranging from 0 to 4. For each class a patient typical signal is displayed
the percentage decrease of the average peak amplitude of the
first five movements with respect to the average amplitude of
the last five movements; a high value suggests severe diffi-
culty in maintaining a constant maximum inclination. On the
other hand, the mean and max value of thigh inclination find
their motivation considering that one of the common treats of
bradykinesia is the inability to perform wide movements. One
can expect to measure wider thigh movements (i.e., larger
values of the inclination signal) on little affected patients, and
vice-versa. The maximum acceleration and angular velocity
reflects slowness in the execution of movements. The maxi-
mum absolute values of the measured angular velocities and
accelerations are taken as features representing such aspect of
bradykinesia. Furthermore, also RMS values of both accel-
eration and gyroscope signals are included into the study.
Finally, the ranges of acceleration and angular velocity have
proven to exhibit smaller values in patients suffering from
bradykinesia with respect to controls, due to the limited range
of movements performed by PD patients.
The dominant frequency fd, i.e., the frequency for which
the PSD of both acceleration and angular velocity is max-
imum, is selected as the relevant feature in the frequency
domain, along with the ratio of dominant frequency power
to total power, also addressed in Ref. [30] for the classifica-
tion of tremor, dyskinesia and bradykinesia.
Finally, spectral signal entropy, i.e., Shannon entropy
evaluated in the frequency domain, was used for the quantifi-
cation of bradykinesia, dyskinesia and tremor with help of






where P(m) is the estimated probability mass function of the
signal power spectrum of acceleration and angular velocity
data.
A preliminary analysis has revealed that the severity of
bradykinesia is strictly correlated with the angular velocity
along the direction perpendicular to the femur in the coro-
nal plane. Figure 3 reports typical trends of this velocity,
measured on patients scored UPDRS = 0 or 1 and UPDRS
= 2–4. Both the signal amplitude and regularity decrease
along with the severity of bradykinesia. The same trend can
be appreciated considering the accelerometer signals along
z-axis (Fig. 4).
On the other hand, in Fig. 5, boxplots are depicted
for two acceleration-based features: maximum value and
signal range. Data have been split in subsets, grouping
patients characterized by the same UPDRS LA evalua-
tion.
A neat decreasing trend along with the severity of the
bradykinesia can be appreciated, even though each single
feature alone is unable to uniquely classify the UPDRS class
(the interquartile ranges are indeed superimposed).
Similar considerations hold true as for the maximum angu-
lar velocity and the range of angular velocity, evaluated on
the gyroscope signal (boxplots in Fig. 6). Many features
addressed in this paper exhibit similar trends (diagrams not
reported for brevity).
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Fig. 4 Time trajectories of z-axis acceleration for LA MDS-UPDRS scores ranging from 0 to 4. For each class a patient typical signal is displayed
3.3 FOG detection: experimental protocol
According to Refs. [36,58], the best position of a single
smartphone on the body for detecting gait impairments is
waist, at lower back level, as it is close to the body center of
mass and ensures maximum patient coziness.
In our experiments, participants executed the 6MWT;
originally employed in cardiological rehabilitation, it is
largely employed also in neurology [70] due to its ease of
setting up, patient tolerance and reproducibility. After the
smartphone was secured on the participants’ waist by means
of a Velcro belt (see Fig. 7), they were asked to walk back and
forth along a 10-m hallway for 6 min at their preferred pace.
Inertial data were locally stored by means of SensorLog. Par-
ticipants were free of using their usual walking aids, and of
quitting the test in any moment. The tests were performed
under the supervision of clinical personnel.
Activities included walking, turning, standing, and possi-
bly FOG episodes; no FOG provocation test was employed.
To guarantee the patients’ privacy, as well as to test our
tool in realistic working conditions, we have decided not
to rely on any video recording. Instead, a chronometer was
run simultaneously to the data-recording session, and FOG
episodes, voluntary gait pauses, hesitations and gait asym-
metries manually annotated by the clinician. Once collected,
data were exported in CSV format and processed offline using
Matlab, version 2018a for Windows 10. We recorded more
than 3.5 h of acceleration signals, gathering 33 FOG events
for a total of 4 min of registration. The histogram of the dura-
tion of the captured FOG episodes is reported in Fig. 8. Most
episodes exhibited a duration inferior to 5 s, even though
some of them lasted 20 s or more. This is in line with the
expected distribution of FOG event duration [71].
Even though also gyroscopic data have been recorded, in
this paper, we only present results related to accelerometer
data, as they have proven to provide good classification per-
formance.
Signals were band-pass filtered (0.5–15 Hz) with a 10-
order Butterworth filter. Cutoff frequencies were chosen
taking into account that the acceleration signal during loco-
motion lies in the band 0.5–3 Hz, whereas the signal during
FOG episodes lies in the band 3–8 Hz [44,56].
Each session of data acquisition was manually labeled
using a Matlab graphic user interface (GUI), to identify
signal segments related to different activity classes: walk-
ing (WA), turning (TU), standing (ST), and FOG. To reduce
the computational time, from the total 3.5 h recording, for
each patient, only a characteristic piece of 15 s was extracted
from WA, TU and ST; while the whole FOG signal was
kept. The resulting 33 min long track was segmented into
2 s-windows, with 50% overlap. This window duration is
a tradeoff between resolution and computational efficiency,
keeping in mind that the shortest FOG episodes carrying sig-
nificant clinical information exhibit a duration of about 2
s [56]. The set of candidate features taken into account in
the present work has been defined after a direct analysis of
the signal kinematic parameters most suitable to distinguish
FOG, and taking into account literature on similar studies
[36,58]. The list of the features selected in this paper is
reported in Table 4. Among them, the total power is defined
as the signal power lying in the whole signal band. The
freeze ratio is defined as the ratio between signal power in
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Fig. 5 Boxplot of the maximum acceleration value (a) and the range
of the signal values (b)
the freeze band (3–10 Hz) and total signal power. The PSD
peak, defined as the frequency value corresponding to the
maximum of the PSD of the acceleration signal. The Num-
ber of peaks is defined as the number of peaks exceeding
a given threshold, experimentally selected to be equal to the
standard deviation of the corresponding signal. We have been
evaluated all the addressed candidate features in each signal
window, for all subjects, and for the three signal components
(vertical, middle-lateral, anterior-posterior). We kept sepa-
Fig. 6 Boxplot of the maximum angular velocity value (a) and the
range of the signal values (b)
rated each class of activity performed during the test, i.e.,
WA, TU, ST and FOG.
3.4 LA estimation: results using the smartphone
In this section, the selected features for LA estimation are
input to several classification methods. A leave-one-out vali-
dation criterion has been employed, i.e., each element of the
dataset is used to test the performance of each algorithm,
123
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Fig. 7 Experimental setup for FOG detection
Fig. 8 Recorded FOG episode duration
trained using the remaining elements. The performance of
each model in terms of correct classification rate of each
UPDRS class, and overall accuracy, is summarized in Table
5. For the sake of brevity, for each tested ML approach ,model
parameters (e.g., Kernel function and scale for SVM, neigh-
borhood dimension, distance metric and weight for kNN)
were tuned to minimize the misclassification rate and only
the best resulting models are listed.
We can notice that the NN model (2 hidden layer of
16 neurons each with hyperbolic tangent sigmoid trans-
fer function) exhibits the best performance for both overall
(accuracy 76.1%) and single class classification, with the
only exception of UPDRS 4 patients. However, this case is
Table 4 List of features used for FOG detection
Feature Description
n. 1 Total power
n. 2 Freeze ratio
n. 3 Power spectral density peak
n. 4 Standard deviation of signal in a time window
n. 5 Number of peaks exceeding a given threshold (set to
std in this work)
n. 6 Number of signal zero crossings in a time window
not significant, as patients are hardly able to perform LA
due to the severity of their condition. The correct classifica-
tion rate of patients belonging to UPDRS classes 0–3 ranges
between 70 and 86.7%. SVM and kNN yield satisfactory
results in classifying UPDRS 1 patients (77.4% and 79.8%),
but their performance is lower for other UPDRS classes. LDA
and Decision Tree algorithms yield overall less satisfactory
performance.
Due to the random initialization of weights between neu-
rons, NN model was run 20 times for each test. Continuous
classification outcomes are averaged and then discretized to
be compared to UPDRS scale; Fig. 9 reports the final con-
fusion matrix. The performance is very sound, with the best
classification results achieved with true UPDRS = 1 and true
UPDRS = 3. An interesting aspect is that this method classi-
fies incorrectly only by one step on the UPDRS scale. As also
discussed in Ref. [32], such a variability is comparable with
the inter-rater variability: the UPDRS evaluation performed
by several neurologists is often non-homogeneous, due to the
difficulty in discriminating between adjacent classes in cases
of intermediate gravity. Hence, NN seems a good candidate
to mimic the UPDRS clinical evaluation as for LA.
To achieve better insight in the behavior of the proposed
classifiers, Fig. 10 reports the cumulative probability distri-
bution (CDF) of the several methods addressed in this paper,
as a function of the absolute error between the UPDRS value
yielded by the algorithm and that provided by the neurologist.
Even though, as for the independent variable, only integer
values are considered, in accordance with the MDS-UPDRS
scale, it can be appreciated that, even though all the proposed
algorithms yield a rather steep curve, the NN method steadily
outperforms the competing algorithms.
Finally, in Table 6, the performance of the proposed
methods are summarized, in terms of accuracy, sensitivity,
specificity and area under the curve (AUC). For the sake
of comparison, the best results achieved by the ML meth-
ods addressed in Refs. [33,34] for the same LA test are also
reported. From these results, we can conclude that the NN
largely outperforms the other tested ML techniques, achiev-
ing very satisfactory performance scores.
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Table 5 LA estimation: correct classification rate and accuracy for each UPDRS class (leave-one-out validation)
Method UPDRS 0 (%) UPDRS 1 (%) UPDRS 2 (%) UPDRS 3 (%) UPDRS 4 (%) Accuracy (%)
SVM linear 42.5 77.4 52.5 46.7 40 60.9
kNN (k = 5) 40 79.8 50 46.7 40 60.9
Neural network 80 77.4 70 86.7 40 76.1
L.D. analysis 62.5 46.4 52.5 66.7 60 53.3
Decision tree 37.5 75 37.5 60 0 55.4
Fig. 9 LA estimation: confusion matrix based on the results of the
supervised neural network model
Fig. 10 LA estimation: CDF vs. absolute error achieved by the pro-
posed ML methods
Table 6 LA estimation: performance measures for several ML methods
Method Accuracy (%) Sensitivity (%) Specificity (%) AUC
NN 76.1 58.7 80.0 0.92
SVM 60.9 51.6 42.5 0.87
kNN, k = 5 60.9 52.2 40.0 0.87
[33,34] 43.0 27.2 84.5 0.87
Fig. 11 LA estimation: confusion matrix based on the results from the
supervised Neural Network model for binary classification
Our classification method does not aim to replace the clin-
icians in the assessment of the clinical stage of the disease.
Instead, it is a supporting tool for the clinicians to achieve
a better follow-up of their patients. Hence, the algorithm
should be able to appreciate variations in the patient’s condi-
tions so that the neurologist can optimize the drug treatment.
To this end, we have also tested a classification model able to
distinguish between slight (true UPDRS 0 and 1) and severe
motor condition (true UPDRS 2, 3 and 4). We refer to the NN
model as it has shown the best overall performance. Figure
11 reports the confusion matrix achieved by this method in
the binary classification task.
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Table 7 FOG estimation: results of tenfold cross validation on training
data
Sample Performance Value Total windows




The correct classification percentage is 92.9%, with only
3 (10) misclassifications over 121 (60) true mild cases (true
severe, respectively). We believe that this result is very
promising. It opens the possibility of a remote monitoring
of the patient’s bradykinesia using a single smartphone, with
a trivial and safe procedure that can be self-managed by the
patient him/herself.
3.5 FOG detection: results using the smartphone
In this section, we present the classification results achieved
for the detection of FOG episodes using a single smartphone.
The features selected in Sect. 3.5 are input to a Support Vec-
tor Machine (SVM). This classification algorithm is devised
to obtain high performance for unlearned data, they have the
highest recognition rate among many known classifiers [59]
and provide good results in FOG detection problems [?] [36].
SVM with Linear kernel was found in this work to provide
the higher accuracy. A tenfold cross validation was run on
a training data set encompassing, for each PD participant,
a typical segment of each activity class (WA, TU, ST), and
the available FOG episodes (total signal duration: 33 min).
This validation method has been selected to ease the compar-
isons with other published work [37,41,58,60]. Sensitivity,
specificity, precision and accuracy are reported in Table 7.
We can appreciate that specificity, precision and accuracy
are very satisfactory. In particular, specificity exceeds 98%.
The sensitivity is slightly inferior (81.2%); however, as the
main goal of the algorithm is to gather information about the
daily trend of FOG episodes (e.g., whether they tend to cluster
during specific day moments or not), in accordance with the
clinicians we have set the method to trade high specificity
with a possibly inferior sensitivity, to avoid a high rate of
false FOG detection. Furthermore, a leave-one-patient-out
validation was performed to assess classification robustness,
yielding to a mean detection rate of 80.0% of FOG windows
per patient.
The receiver-operating characteristic (ROC) curve of the
classifier is shown in Fig. 12. It is worth noticing that the
AUC is 97.96, so confirming the excellent performance of
the implemented model. Furthermore, high specificity (over
97.5%) persist for a wide range of sensitivity values (until
about 87%).
Fig. 12 FOG estimation: ROC curve of the proposed SVM model
It is also worth noticing that the processing time in the test
phase is less than 0.5 s for a 10-s-long signal. This makes the
algorithm suitable for a real-time implementation.
Finally, the proposed method is compared with other
recent studies, addressing FOG detection and employing a
waist-mounted device. The results are shown in Table 8.
Specificity, precision and accuracy achieved by the proposed
method outperform the best results from the algorithms under
comparison by 4%, 19% and 9%, respectively. Despite sensi-
tivity is actually outperformed by other algorithms, the high
precision value (i.e., the probability that a window classified
as FOG actually contains FOG) rises its meaningfulness, as
the sensitivity alone is little significant if not associated to a
high precision value.
A limitation of the presented study is that few FOG
episodes have been identified. Actually, as measures were
obtained during the pre-scheduled annual neurological visit,
we could not employ any FOG provocation test. Most par-
ticipants were in daily on state, and no selection based on
previous history of FOG was implemented. For the sake of
comparison, in Refs. [41,55] about 10 min of FOG have been
registered thanks to FOG provocation (e.g., dual tasking). In
Ref. [37], 20 min of FOG have been collected, with hospi-
talized patients in their off state. In Refs. [58,60], up to 93
FOG min have been recorded due to a complex experimental
protocol implementing the tests under levodopa suppres-
sion, hence hospitalized patients; only 12 min are related
to patients in on state.
Another possible limitation is that present data refer to
supervised activities. To achieve a continuous and long-term
monitoring of patient during ADL, new data are being col-
lected to enlarge the set of performed activities to encompass
most ADL situations.
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Table 8 FOG estimation: comparison between the proposed method and similar recent studies











Year 2016 2016 2016 2017 2018 2018
Dataset 20 PD 21 PD 10 PD 21 PD 32 PD 38 PD, 21 Control
Device Smartphone IMU Accelerometers IMU Smartphone Smartphone
Model Threshold-based SVM CWT CNN CNN SVM
Sensitivity (%) 87.6 74.7 83.5 92.6 93.8 81.2
Specificity (%) 95.0 79.0 67.2 88.7 90.1 98.7
Precision (%) 69.6 n.r. n.r. n.r. n.r. 88.7
Accuracy (%) 84.4 n.r. n.r. 87.9 91.8 96.9
n.r. non reported
Fig. 13 SensorTile™
4 PDmonitoring using SensorTile™
Smartphones are widespread, easy to use and well-accepted
devices. Moreover, the characteristics of the embedded iner-
tial sensors are sufficient for human motion analysis. On the
other hand, significant size, low battery autonomy and inter-
ference with other applications during data acquisition, make
smartphones not suitable for a long-term monitoring. Thus,
moving in the direction of acquiring data related to ADL, we
consider the option to replace the smartphone with a Sensor-
Tile module.
4.1 SensorTile™
SensorTile is a compact wearable device integrating the
functionalities of an IMU (accelerometers, gyroscopes and
magnetometer are included), together with powerful process-
ing capabilities provided by a 80 MHz MCU and additional
environmental sensors (barometer, humidity and temperature
sensors) plus a microphone. Sensor data streaming is allowed
via USB, logging on SD card and via Bluetooth Low Energy.
The device consists of a plastic box hosting a 100
mAh Li-Ion battery and the SensorTile module soldered
on the SensorTile cradle (Fig. 13), all provided with the
STLKT01V1 development kit by STMicroelectronicsTM.
Fig. 14 SensorTile core system
The STEVAL-STLCS01V1 SensorTile core system is
a tiny, 13.5 mm × 13.5 mm square-shaped IoT module
(Fig. 14) equipped with a low-power 80-MHz MCU, Blue-
tooth low-energy connectivity and a wide spectrum of motion
and environmental MEMS sensors. The main components
include:
1. MP34DT05-A digital microphone.
2. STM32L476JG 32-bit ultra-low-power MCU with
CortexM4F.
3. LSM6DSM iNEMO inertial module integrating a 3-axis
accelerometer and a 3-axis gyroscope.
4. LSM303AGR Ultra-compact high-performance eCom-
pass module integrating a ultra-low power 3-axis
accelerometer and a 3-axis magnetometer.
5. LPS22HB MEMS nano-pressure sensor.
6. BlueNRG-MS Bluetooth low-energy network processor.
The STLCR01V1 SensorTile compact cradle (Fig. 15) is
designed to host the SensorTile core system and to expand
the functionalities of the module. Its main components are:
1. Solderable SensorTile footprint.
2. HTS221 temperature and humidity sensor.
3. Standalone linear Li-Ion battery charger.
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Fig. 15 SensorTile cradle
Table 9 iNemo inertial module main characteristics
Accelerometer Gyroscope
Full scale ±2 to ± 16 g ±125 to ± 2000 dps
Output resolution 16 bit
Output data rate 12.5 Hz to 6.6 KHz
4. MicroSD card socket.
5. Battery connector.
6. USB type A to Mini-B USB connector for power supply
and communication.
7. Power switch.
8. SWD connector for programming and debugging.
Compared with commercial smartphones, this tiny wear-
able device provides noticeable benefits as for long-term
monitoring of PD patients
• Small size The reduced dimensions and weight of the
device enable long-term monitoring. In fact, given the
device coziness, it does not interfere with patient’s ADL.
• Positioning Given the very small size of the device, many
body locations, such as wrist and ankle, can be used for
data acquisition in an unobtrusive way. Thus, detection
and monitoring of further PD symptoms (e.g., tremor,
upper limb dyskinesia) and more accurate measures of
gait parameters may be enabled.
• Sensors characteristics The iNemo inertial module pro-
vides state-of-the-art low-power 3D accelerometer and
3D gyroscope with settable Full-Scale Range, very high
sensitivity and settable sample frequency (as shown in
Table 9).
• Power consumption The device is extremely energy effi-
cient, given the low-power consumption of the integrated
MCU and inertial sensors, together with energy-saving
power modes provided (iNemo inertial module provide
a low-power mode for data acquisition with sample fre-
quency up to 52 Hz, that is suitable for the purposes of
our study).
• No interference Since SensorTile is a dedicated hard-
ware, there is no interference of background applications
running on the device. Data acquisition on smartphones
may present gaps; this scenario occurs when other appli-
cations, installed on the device, employ inertial sensors.
4.2 SensorTile™ background
Due to its versatility, the SensorTile module has been applied
in many different areas, from health (e.g., [72,73]) to sport
(e.g., [74,75]). In [72], the authors deploy a platform (i.e.,
neMEMSi-Smart), produced by STMicroelectronics and
similar to the SensorTile module, to assess gait and balance
for elderly people. The platform is the core of a wireless
Body Sensor Network, mounted on different body segments
depending on the task performed. To evaluate the gait param-
eters, one module was mounted on the ankle, and the subjects
were asked to perform the 6MWT. On the other hand, as for
the stability evaluations, two modules were employed, the
first one placed on the trunk and the other one on the fore-
arm. In both cases, signals collected through the platform (3D
orientation, acceleration, angular velocities and 3D compass)
were stored on an SD card and post-processed.
In Ref. [76], human activities are classified in free-living
conditions using 3D acceleration signals. In this work, two
feed-forward artificial neural networks are loaded into the
SensorTile MCU, mounted on a wristband. The communica-
tion is provided by the embedded BLE module. Furthermore,
the authors overcome consumption issues, coupling the mod-
ule with organic photovoltaic solar cells installed on the
same wristband. This solution allows them to improve the
battery autonomy. Torti et al. [73] have developed a recur-
rent neural network suitable to be incorporated into the
MCU. The authors aim to detect falls in real-time during
ADL, using a tri-axial accelerometer. After having veri-
fied the project feasibility in terms of data storage, memory
consumption, battery lifetime, the developed software was
embedded in the SensorTile MCU for the validation. In Ref.
[74,75], SensorTile was deployed to objectively evaluate ath-
letic performance and monitor sport activity. Iervolino et al.
[74] performed a preliminary gait analysis in both walking
and running conditions, with the device located on the run-
ner ankle. Acceleration data were processed to achieve an
early activity recognition. Then, gait parameters (e.g., stride
period, stance period) were gathered during running/walking
sessions. Finally, the work described in Ref. [77] validates the
use of the BLE technology in applications that require high
throughput. Human activities monitoring through a body area
network (BAN) are addressed, and the BLE performance
evaluated on different sensor nodes, including SensorTile.
This latter turns out to provide the best performance in
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terms of efficiency. This result corroborates the use of a
such platform for biomedical applications. To the best of our
knowledge, there is still no SensorTile application for PD
patients, aiming at building up an electronic diary to keep a
record of PD symptom progression in unsupervised environ-
ment.
4.3 Inertial signal assessment using SensorTile™
The performance of the algorithms developed for LA and
FOG assessment, and making use of the smartphone, still
hold valid or are improved if this latter is replaced with a
SensorTile module. In fact, the technical characteristics of
inertial sensors embedded in SensorTile are superior to that
of smartphone sensors, provided that these latter fully meet
our motion analysis requirements. Hence, we can conclude
that the inertial signals acquired through the two devices are
both valid for the application at hand. This is of fundamental
importance, as it allows to achieve interoperability and to run
the classification algorithms independently of the addressed
platform.
To validate these claims, we have performed gait data
acquisition on a subject performing ADL activities (e.g.,
walking, turning, postural transitions). Both devices were
located in the same smartphone belt and secured to the sub-
ject lower back. Data were saved on SD card and exported in
CSV format for offline processing on Matlab. The records
of the two nodes were synchronized and residual delay was
removed offline. Figure 16 shows the resulting inertial sig-
nals related to different activities.
As expected, the difference between the two inertial sig-
nals can be hardly appreciated. Still, the higher sensitivity
of the SensorTile inertial sensors, together with the slightly
different position of the two devices, can explain the result-
ing small gap in terms of signal shift. Such a gap is almost
undetectable as for angular velocity signal (Fig. 16b), due
to the lower sensitivity to the rapid small-scale vibrations.
In any case, it is worth to emphasize that such difference is
so small that the performance of the developed algorithms,
validated on previous data acquisitions, can be considered
valid also if SensorTile is employed. The added value of this
result is that the to-be-implemented electronic diary can be
fully interoperable between the two platforms.
5 Discussion
Recently, the Movement Disorder Society—Task Force on
Technology pointed out that a clinical assessment of PD
based on pre-scheduled outpatient visits is suboptimal. They
stated that obtaining reliable longitudinal data during ADL
is crucial, and proposed a roadmap to make the introduction
of mobile technologies more effective for patients, clini-
Fig. 16 Smartphone and SensorTile comparison in typical ADL
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cians and caregivers [78]. The main objectives should be
to support clinical diagnosis, implement a better follow-up
of the disease progression, and detect subtle yet signifi-
cant signs and symptoms. They also emphasized that the
algorithm validation is a delicate step. In fact, the gold
standard clinical scales (such as the UPDRS addressed
in this paper) are prone to inter- and intra-rater variabil-
ity, and their accuracy may be outperformed by digital
algorithms; this may account for the suboptimal corre-
lation between the two classed of measures. Moreover,
data taken during ADL are affected by several confound-
ing variables. Nevertheless, these issues should be largely
overcome by the advantages of a continuous monitoring
[78].
5.1 The patient’s and caregiver’s points of view
The main advantage for patients is that the disease pro-
gression could be finely monitored without requiring them
to move to the outpatient department. Besides impos-
sible for economy and resource allocation reasons, this
would also be impractical for patients themselves. Moving
to the hospital is a cause of stress, and implies logis-
tic issues. On the other hand, a fine posology adjustment
can extend the period in which the disease is well con-
trolled, yielding an improved QoL. Psychological benefits
must also be considered; the patient feels more monitored
and safer, and the long-term adherence to the therapy is
promoted. Similar benefits hold for the caregivers. The
patient is expected to have better QoL, more stable mood
and more residual autonomy; less logistic issues should be
faced.
Acceptance deserves some more discussion. We have
interviewed about 100 patients, and they agree that a non-
invasive technology could be well accepted. Of course, it
should not impair ADLs, be unobtrusive, able to catch subtle
changes in physical conditions, to function as a personalized
electronic diary, and to paint a global picture of each single
patient.
Using the smartphone to collect data may be subopti-
mal from the patient’s point of view, due to the relatively
high weight and size. On the other hand, smartphone is
a widespread instrument, and does not imply significant
additional cost to the patient. We have performed a pre-
liminary study, in which some patients were asked to
perform the LA measures at home, five times per day.
This task has demonstrated to be feasible and little both-
ersome, even though the supervision of the caregiver was
necessary. Less cumbersome technology such as SensorTile
are expected to be even more manageable, even though it
implies an extra cost to be sustained. This is the reason
why we pursue interoperability of different technological
devices, matching different patient’s needs and require-
ments.
5.2 The professional point of view
Professionals are aware that a PD patient follow-up based on a
yearly, pre-scheduled visit is not adequate, especially in inter-
mediate stages of the disease. They are well ready to accept
technology support to ameliorate the patient’s management,
facilitate decision-making, and catch signs of impairment
before they occur. On the other hand, clinicians are not ready
to manage large amounts of data; hence, the information
should be condensed in periodic reports, plus possible alarms
to be received in the hospital or in the outpatient department.
It must be noticed that, as also discussed in Ref. [78], at
present we lack a proper infrastructure able to transmit and
store such data. Future research must be in the direction of
designing a scalable, open-source, web-based architecture,
able to integrate several types of information, to manage dif-
ferent technology standards, to meet regulatory and security
rules for medical data. The cost effectiveness, in terms of
improved health and reduction of hospital admissions, needs
also to be properly quantified.
6 Conclusion and future work
Home monitoring of PD motor symptoms can provide valu-
able information to check PD progression, motor fluctuations
and response to drug therapy. To this end, in this study we
have implemented algorithms using inertial data from wear-
able sensors, to monitor bradykinesia and FOG. In a first
phase, as a feasibility study, we have employed the iner-
tial sensors embedded in a common smartphones; then, we
have addressed the SensorTile platform by STMicroelectron-
ics, to move towards a seamless solution for implementing
a PD patient’s electronic diary. The achieved preliminary
results are very promising, as the addressed ML methods
have yielded excellent results, robustness, limited computa-
tional burden and high generalization capability.
As both smartphone and SensorTile solutions exhibit
pros and cons, we intend to pursue a software solution that
guarantees interoperability between the two systems. Future
developments concern the acquisition of more training data,
especially for the patients with severe conditions (UPDRS
3-4). Furthermore, a patient-specific training of the classi-
ficator could be addressed, leading to further improvement
of the detection performance. A real-time implementation of
the algorithm will be provided, given the computational effi-
ciency of the proposed algorithm. We plan to include more
monitoring tasks in the same wearable device, to provide a
thorough patient follow-up. Finally, we plan to use our tool
in an experimental trial addressing the new drug opicapone
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[79], to measure to what extent this drug is able to limit daily
fluctuations in Parkinson’s disease patient.
Acknowledgements The authors would like to thank the Associazione
Amici Parkinson Piemonte, Turin, and the Orfanelle Nursing Home,
Chieri, for their valuable support in selecting PD patients and control
subjects for our study. The authors would also like to thank STMi-
croelectonics, Agrate Brianza, Italy, for putting the SensorTile module
available for this research.
Open Access This article is distributed under the terms of the Creative
Commons Attribution 4.0 International License (http://creativecomm
ons.org/licenses/by/4.0/), which permits unrestricted use, distribution,
and reproduction in any medium, provided you give appropriate credit
to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made.
References
1. Krupinski EA, Bernard J (2014) Standards and guidelines in
telemedicine and telehealth. Heathcare 2:74–93
2. Jankovic J (2008) Parkinson’s disease: clinical features and diag-
nosis. J Neurol Neurosurg Psychiatry 79(4):368–376
3. Houl JG, Lai EC (2007) Non-motor symptoms of Parkinson’s dis-
ease. Int J Gerontol 1(2):53–64
4. Olanow CW, Kieburtz K, Rascol O, Poewe W, Schapira AH, Emre
MM, Nissinen H, Leinonen M, Stocchi F (2013) Factors predictive
of the development of levodopa-induced dyskinesia and wearing
off in Parkinson’s disease. Mov Disord 28(8):1064–1071
5. Giladi N, Kao R, Fahn S (1997) Freezing phenomenon in patients
with Parkinsonian syndromes. Mov Disord 3:302–305
6. Heremans E, Nieuwboer A, Vercruysse S (2013) Freezing of gait
in Parkinson’s disease: where are we now?”. Curr Neurol Neurosci
Rep 13(6):350
7. Moore O, Peretz C, Giladi N (2007) Freezing of gait affects quality
of life of peoples with Parkinson’s disease beyond its relationships
with mobility and gait. Mov Disord 15:2192–2195
8. Bloem BR, Hausdorff JM, Visser JE, Giladi N (2004) Falls and
freezing of gait in Parkinson’s disease: a review of two intercon-
nected, episodic phenomena. Mov Disord 19(8):871–884
9. Nieuwboer A, Giladi N (2008) The challenge of evaluating freezing
of gait in patients with Parkinson’s disease. Br J Neurosurg 22:S16–
S18
10. Giladi N, Treves TA, Simon ES, Shabtai H, Orlov Y, Kandinov B,
Paleacu D, Korczyn AD (2001) Freezing of gait in patients with
advanced Parkinson’s disease. J Neural Transm 108(1):53–61
11. Goetz CG et al (2008) Movement disorder society-sponsored revi-
sion of the unified Parkinson’s disease rating scale (MDS-UPDRS):
scale presentation and clinimetric testing results. Mov Disord
23(15):2129–2170
12. Goetz CG et al (2007) Movement disorder society-sponsored revi-
sion of the unified Parkinson’s disease rating scale (MDS-UPDRS):
process, format, and clinimetric testing plan. Mov Disord 1:41–47
13. Ramaker C, Marinus J, Stiggelbout AM, van Hilten BJ (2002)
Systematic evaluation of rating scales for impairment and disability
in Parkinson’s disease. Mov Disord 5:867–876
14. Mentzel TQ, Lieverse R, Levens A, Mentzel CL, Tenback DE,
Bakker PR, Daanen HAM, van Harten PN (2016) Reliability and
validity of an instrument for the assessment of bradykinesia. Else-
vier Psychiatry Res 238:189–195
15. Barthel C, Mallia E, Debû B, Bloem BR, Ferraye MU (2016)
The practicalities of assessing freezing of gait. J Parkinsons Dis
6(4):667–674
16. Heremans E, Nieuwboer A, Spildooren J, Vandenbossche J,
Deroost N, Soetens E, Kerckhofs E, Vercruysse S (2013) Cognitive
aspects of freezing of gait in Parkinson’s disease: a challenge for
rehabilitation. J Neural Transm 4:543–557
17. Ehgoetz Martens KA, Ellard CG, Almeida QJ (2014) Does anx-
iety cause freezing of gait in Parkinson’s disease? PLoS One
9(9):e106561
18. Giladi N, Tal J, Azulay T, Rascol O, Brooks DJ, Melamed E, Oertel
W, Poewe WH, Stocchi F, Tolosa E (2009) Validation of the freezing
of gait questionnaire in patients with Parkinson’s disease. Mov
Disord 24(5):655–661
19. Nieuwboer A, Rochester L, Herman T, Vandenberghe W, Emil
GE, Thomaes T, Giladi N (2009) Reliability of the new freezing of
gait questionnaire: agreement between patients with Parkinson’s
disease and their carers. Gait Posture 30(4):459–463
20. Baretta D, Sartori F, Greco A, Melen R, Stella F, Bollini L,
D’Addario M, Steca P (2016) Wearable devices and AI techniques
integration to promote physical activity. In: Proceedings of the
18th international conference on human–computer interaction with
mobile devices and services—AdjunctMobileHCI 16
21. Ureña R, González-Alvarez A, Chiclana F, Herrera-Viedma E,
Moral-Munoz J (2018) Intelligent m-health app to evaluate the
elderly physical condition. In: New Trends in Intelligent Software
Methodologies, Tools and Techniques, vol 303. IOS Press, pp 87–
100. https://doi.org/10.3233/978-1-61499-900-3-87
22. Pinardi S, Sartori F, Melen R (2016) Integrating knowledge arti-
facts and inertial measurement unit sensors for decision support. In:
Proceedings of the 8th international joint conference on knowledge
discovery, knowledge engineering and knowledge management,
vol 3, pp 307–313
23. Hasan H, Athauda DS, Foltynie T, Noyce AJ (2017) Technologies
assessing limb bradykinesia in Parkinson’s disease. J Parkinson’s
Dis 7(1):65–77
24. Arora S, Venkataraman V, Zhan A, Donohue S, Biglan KM, Dorsey
ER, Little MA (2015) Detecting and monitoring the symptoms
of Parkinson’s disease using smartphones: a pilot study. Elsevier
Parkinsonism Relat Disord 21:643–650
25. Griffiths RI, Kotschet K, Arfon S, Xu ZM, Johnson W, Drago J,
Evans A, Kempster P, Raghav S, Horne MK (2012) Automated
assessment of bradykinesia and dyskinesia in Parkinson’s disease.
J Parkinson’s Dis 2(1):47–55
26. Salarian A, Russmann H, Wider C, Burkhard PR, Vingerhoets FJG,
Aminian K (2007) Quantification of tremor and bradykinesia in
parkinson’s disease using a novel ambulatory monitoring system.
IEEE Trans Biomed Eng 54(2):313–322
27. Dai H, Lin H, Lueth TC (2015) Quantitative assessment of parkin-
sonian bradykinesia based on an inertial measurement unit. Biomed
Eng Online 14(1):68
28. Djuric´-Jovicˇic´ M, Petrovic´ I, Jecˇmenica-Lukic´ M, Radovanovic´
S, Dragaševic´-Miškovic´ N, Belic´ M, Miler-Jerkovic´ V, Popovic´
MB, Kostic´ VS (2016) Finger tapping analysis in patients with
Parkinson’s disease and atypical parkinsonism. J Clin Neurosci
30:49–55
29. Heldman DA, Filipkowsk DE, Riley DE, Whitney CM, Walter
BL, Gunzler SA, Giuffrida JP, Mera TO (2012) Automated motion
sensor quantification of gait and lower extremity bradykinesia. In:
Engineering in medicine and biology society (EMBC), 2012 annual
international conference of the IEEE. IEEE, pp 1956–1959
30. Patel S, Lorincz K, Hughes R, Huggins N, Growdon J, Standaert
D, Akay M, Dy J, Welsh M, Bonato P (2009) Monitoring motor
fluctuations in patients with Parkinson’s disease using wearable
sensors. IEEE Trans Inf Technol Biomed 13(6):864–873
31. Galna B, Barry G, Jackson D, Mhiripiri D, Olivier P, Rochester
L (2014) Accuracy of the microsoft kinect sensor for measur-
ing movement in people with Parkinson’s disease. Gait Posture
39(4):1062–1068
123
Journal of Reliable Intelligent Environments
32. Parisi F, Ferrari G, Giuberti M, Contin L, Cimolin V, Azzaro C,
Albani G, Mauro A (2015) Body-sensor-network-based kinematic
characterization and comparative outlook of updrs scoring in leg
agility, sit-to-stand, and gait tasks in Parkinson’s disease. IEEE J
Biomed Health Inform 19(6):1777–1793
33. Giuberti M, Ferrari G, Contin L, Cimolin V, Azzaro C, Albani
G, Mauro A (2015) Assigning updrs scores in the leg agility task
of parkinsonians: can it be done through BSN-based kinematic
variables? IEEE Internet Things J 2(1):41–51
34. Giuberti M, Ferrari G, Contin L, Cimolin V, Azzaro C, Albani G,
Mauro A (2015) Automatic updrs evaluation in the sit-to-stand task
of parkinsonians: kinematic analysis and comparative outlook on
the leg agility task. IEEE J Biomed Health Inform 19(3):803–814
35. Zach H, Janssen AM, Snijders AH, Delval A, Ferraye MU, Auff E,
Weerdesteyn V, Bloem BR, Nonnekes J (2015) Identifying freez-
ing of gait in Parkinson’s disease during freezing provoking tasks
using waist-mounted accelerometry. Parkinsonism Relat Disord
21(11):1362–1366
36. Ahlrichs C, Samà A, Lawo M, Cabestany J, Rodríguez-Martín D,
Pérez-López C, Sweeney D, Quinlan LR, Laighin G, Counihan
T, Browne P, Hadas L, Vainstein G, Costa A, Annicchiarico R,
Alcaine S, Mestre B, Quispe P, Bayes A, Rodríguez-Molinero A
(2016) Detecting freezing of gait with a tri-axial accelerometer in
Parkinson’s disease patients. Med Biol Eng Comput 54(1):223–233
37. Rezvanian S, Lockhart T (2016) Towards real-time detection of
freezing of gait using wavelet transform on wireless accelerometer
data. Sensors 16(4):475
38. Djuric-Jovicic MD, Jovicic NS, Radovanovic SM, Stankovic ID,
Popovic MB, Kostic VS (2014) Automatic identification and classi-
fication of freezing of gait episodes in Parkinson’s disease patients.
IEEE Trans Neural Syst Rehabil Eng 22(3):685–694
39. Kim H, Lee HJ, Lee W, Kwon S, Kim SK, Jeon HS, Park H, Shin
CW, Yi WJ, Jeon BS, Park KS (2015) Unconstrained detection of
freezing of gait in Parkinson’s disease patients using smartphone.
In: 37th annual international conference of the IEEE engineering
in medicine and biology society, vol 2015, pp 3751–3754
40. Coste CA, Sijobert B, Pissard-Gibollet R, Pasquier M, Espiau B,
Geny C (2014) Detection of freezing of gait in Parkinson disease:
preliminary results. Sensors 14(4):6819–6827
41. Capecci M, Pepa L, Verdini F, Ceravolo MG (2016) A smartphone-
based architecture to detect and quantify freezing of gait in
Parkinson’s disease. Gait Posture 50:28–33
42. Moore ST, Yungher DA, Morris TR, Dilda V, Macdougall HG,
Shine JM, Naismith SL, Lewis SJ (2013) Autonomous identifi-
cation of freezing of gait in Parkinson’s disease from lower-body
segmental accelerometry. J NeuroEng Rehabil 10(1):19
43. Jovanov E, Wang E, Verhagen L, Fredrickson M, Fratangelo R
(2009) DeFOG—a real time system for detection and unfreezing
of gait of Parkinson’s patients. In: 2009 annual international con-
ference of the IEEE engineering in medicine and biology society,
vol 2009, pp 5151–5154
44. Bachlin M, Plotnik M, Roggen D, Maidan I, Hausdorff JM, Giladi
N, Troster G (2010) Wearable assistant for Parkinsons disease
patients with the freezing of gait symptom. IEEE Trans Inf Technol
Biomed 14(2):436–446
45. Tripoliti EE, Tzallas AT, Tsipouras MG, Rigas G, Bougia P,
Leontiou M, Konitsiotis S, Chondrogiorgi M, Tsouli S, Fotiadis
DI (2013) Automatic detection of freezing of gait events in
patients with Parkinson’s disease. Comput Methods Progr Biomed
110(1):12–26
46. Mazilu S (2015) Gait, wrist and sensors: detecting freezing of gait
in Parkinson’s disease from wrist movement. In: 2015 IEEE Inter-
national Conference on Pervasive Computing and Communication
Workshops, pp 583–588
47. Buttussi F, Chittaro L (2008) Mopet: a context-aware and user-
adaptive wearable system for fitness training. Artif Intell Med
42(2):153–163
48. Lane N, Mohammod M, Lin M, Yang X, Lu H, Ali S, Doryab A,
Berke E, Choudhury T, Campbell A (2011) Bewell: a smartphone
application to monitor, model and promote wellbeing. In: 5th inter-
natioal ICST conference on pervasive computing technologies for
healthcare
49. Albert D, Satchwell BR, Barnett KN (2010) Heart monitor-
ing system usable with a smartphone or computer. http://www.
freepatentsonline.com/y2017/0215755.html
50. Nickel C, Busch C, Rangarajan S, Mobius M (2011) Using hidden
Markov models for accelerometer-based biometric gait recogni-
tion. CSPA 7th Intl colloquium Sig Process Appl 58–63
51. Fikri M, Fahmi A, Negara P, Sayeed S, Choi D (2012) Classification
algorithms in human activity recognition using smartphones. Int J
Comput Inf Eng 6(8):77–84
52. Bayat A, Pomplun M, Tran DA (2014) A study on human activity
recognition using accelerometer data from smartphones. Procedia
Comput Sci 34(C):450–457
53. Capela NA, Lemaire ED, Baddour N (2015) Feature selection for
wearable smartphone-based human activity recognition with able
bodied, elderly, and stroke patients. PLoS One 10(4):1–18
54. Mazilu S, Hardegger M, Zhu Z, Roggen D, Troster G, Plotnik M,
Hausdorff JM, Troester G (2012) Online detection of freezing of
gait with smartphones and machine learning techniques. In: 6th
IEEE international conference on pervasive intelligence and tech-
nology for healthcare, vol 3, pp 123–130
55. Kim HB, Lee HJ, Lee WW, Kim SK, Jeon HS, Park HY, Shin
CW, Yi WJ, Jeon B, Park KS (2018) Validation of freezing of gait
monitoring using smartphone. Telemed E-Health 24(12):1–6
56. Moore ST, MacDougall HG, Ondo WG (2008) Ambulatory moni-
toring of freezing of gait in Parkinson’s disease. J Neurosci Methods
167(2):340–348
57. Tzallas AT, Tsipouras MG, Rigas G, Tsalikakis DG, Karvounis EC,
Chondrogiorgi M, Psomadellis F, Cancela J, Pastorino M, Wald-
meyer MT, Konitsiotis S, Fotiadis DI (2014) Perform: a system for
monitoring, assessment and management of patients with Parkin-
son’s disease. Sensors 14(11):21329–57
58. Rodríguez-Martín D, Samà A, Pérez-López C, Català A, Arostegui
JMM, Cabestany J, Bayés A, Alcaine S, Mestre B, Prats A, Crespo
MC, Counihan TJ, Browne P, Quinlan LR, Laighin G, Sweeney
D, Lewy H, Azuri J, Vainstein G, Annicchiarico R, Costa A,
Rodríguez-Molinero A (2017) Home detection of freezing of gait
using Support Vector Machines through a single waist-worn triaxial
accelerometer. PLoS One 12(2):e0171764
59. Hable R, Christmann A (2011) On qualitative robustness of support
vector machines. J Multivar Anal 102(6):993–1007
60. Camps J et al (2018) Deep learning for freezing of gait detection
in Parkinson’s disease patients in their homes using a waist-worn
inertial measurement unit. Knowl Based Syst 139:119–131
61. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of
clinical diagnosis of idiopathic Parkinson’s disease: a clinico-
pathological study of 100 cases. J Neurol Neurosurg Psychiatry
55:181–184
62. Wooten GF, Currie LJ, Bovbjerg VE, Lee JK, Patrie J (2004) Are
men at greater risk for Parkinson’s disease than women? J Neurol
Neurosurg Psychiatry 75:637–639
63. Wang J, Chen R, Sun X, She MFH, Wu Y (2011) Recognizing
human daily activities from accelerometer signal. Procedia Eng
15:1780–1786. https://doi.org/10.1016/j.proeng.2011.08.331
64. Morrow MMB, Hurd WJ, Fortune E, Lugade V, Kenton R (2014)
Accelerations of the waist and lower extremities over a range of
gait velocities to aid in activity monitor selection for field-based
studies. J Appl Biomech 30(4):581–585
123
Journal of Reliable Intelligent Environments
65. Grigas V, Eidukynas V, Domeika A (2014) Acceleration based
evaluation of the human walking and running parameters. JVE
11(1):506–510
66. Alan HF, Arnrich B, Ersoy C, Cinaz B (2014) Sensor Log: A
mobile data collection and annotation application. In: 22nd IEEE
Signal Processing and Communications Applications Conference,
pp 1375–1378
67. Bonato P, Sherrill DM, Standaert DG, Salles SS, Akay M (2004)
Data mining techniques to detect motor fluctuations in Parkinson’s
disease. In: Engineering in medicine and biology society, 2004.
IEMBS’04. 26th annual international conference of the IEEE.
IEEE, vol 2, pp 4766–4769
68. Kim J, Kwon Y, Kim Y, Chung H, Eom G, Jun J, Lee J, Koh S,
Park BK, Kwon D (2012) Analysis of lower limb bradykinesia in
Parkinson’s disease patients. Geriatr Gerontol Int 12(2):257–264
69. Tsipouras MG, Tzallas AT, Rigas G, Tsouli S, Fotiadis DI, Konit-
siotis S (2012) An automated methodology for levodopa-induced
dyskinesia: assessment based on gyroscope and accelerometer sig-
nals. Artif Intell Med 55(2):127–135
70. Marrie RA, Goldman MD, Cohen JA (2008) Evaluation of the six-
minute walk in multiople sclerosis subjects and healthy controls.
Mult Scler 14:383–390
71. Lamberti P, Armenise S, Castaldo V, De Mari M, Iliceto G, Tronci P,
Serlenga L (1997) Freezing gait in Parkinson’s disease. Eur Neurol
38(4):297–301
72. Caldara M, Locatelli P, Comotti D, Galizzi M, Re V, Dellerma N,
Corenzi A, Pessione M (2015) Application of a wireless BSN for
gait and balance assessment in the elderly. 2015 IEEE 12th Int Conf
Wearable Implantable Body Sens Netw, BSN 2015 405–412
73. Torti E, Fontanella A, Musci M, Blago N, Pau D, Leporati F, Piastra
M (2018) Embedded real-time fall detection with deep learning on
wearable devices. In: 2018 21st euromicro conference on digital
system design (DSD), pp 405–412
74. Iervolino R, Bonavolontà F, Cavallari A (2017) A wearable device
for sport performance analysis and monitoring. In: 2017 IEEE
International Workshop on Measurement and Networking
75. Lombardo L, Iannucci L, Gullino A (2018) An inertial-based sys-
tem for golf assessment. In: I2MTC 2018—2018 IEEE Int Instrum
Meas Technol Conf: Discovering New Horiz Instrum Meas, Proc
1–6
76. Nicosia A, Pau D, Giacalone D, Plebani E, Bosco A, Iacchetti A
(2018) Efficient light harvesting for accurate neural classification
of human activities. In: 2018 IEEE international conference on
consumer electronics, ICCE 2018, vol 2018, pp 1–4
77. Tosi J, Taffoni F, Santacatterina M, Sannino R, Formica D (2018)
Throughput analysis of BLE sensor network for motion tracking
of human movements. IEEE Sens J PP(c):1
78. Espay AJ et al (2019) A roadmap for implementation of patient-
centered digital outcome measures in Parkinson’s disease obtained
using mobile heath technologies. Mov Disord. Wiley Online
Library, New York
79. Ferreira JJ, Lees A, Rocha JF, Poewe W, Rascol O, Soares da Silva P
(2015) Opicapone as an adjunct to levodopa in patients with parkin-
son’s disease and end-of-dose motor fluctuations: a randomised,
double-blind, controlled trial. Lancet Neurol 15(2):154–165
Publisher’s Note Springer Nature remains neutral with regard to juris-
dictional claims in published maps and institutional affiliations.
123
